Advertisement
News
Advertisement

ResMed slumps on disappointing U.S. sales and missed Q2 earnings

Fri, 01/24/2014 - 4:11pm
Mass Device

ResMed misses Wall Street's Q2 earnings expectations as U.S. sales fall shorter than projected.

Shares of respiratory devices maker ResMed (NYSE:RMD) dropped more than 6% today after the company reported its Q2 earnings, missing Wall Street's expectations.

ResMed CEO Mick Farrell had his own regrets about the quarter, saying that regulatory issues hindered U.S. sales but that the path ahead looks promising.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading